Home
Conditions
Squamous Cell Carcinoma of Head and Neck

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

NCT02499120

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: UC San Diego Medical Center - La Jolla (Thornton Hospital) La Jolla, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

UC San Diego Medical Center- Hillcrest San Diego, California, United States

University Medical Center, lnc.:DBA University of Louisville Hospital Louisville, Kentucky, United States

View all 71 locations

View Trial Details

Completed

Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC

NCT03624231

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany

Vivantes Klinikum Neukölln Berlin, Germany

Charité Comprehensive Cancer Center Berlin, Germany

View Trial Details

Completed

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

NCT00820248

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada

BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View all 19 locations

View Trial Details

Completed

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

NCT04601402

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00079053

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
Locations: London Regional Cancer Program London, Canada

CHUM - Hopital Notre-Dame Montreal, Canada

View Trial Details

Completed

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT01054625

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations: Cliniques Universitaires SaintLuc Brussels, Belgium

Uz Leuven - Campus Gasthuisberg Leuven, Belgium

Uzsoki Hospital Budapest, Hungary

Vas Megye es Szombathely Szombathely, Hungary

View Trial Details

Completed

Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer

NCT03281499

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study

NCT03575598

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

NCT02207439

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

NCT04452214

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +28 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States

Hospital of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck trial results

Related conditions